tuhurabio.com (HURA): Market Value

Graphic logo of TuHURA Biosciences, Inc. (HURA)

TuHURA Biosciences possesses significant pricing power due to its unique IFx vaccines, which trigger the immune system to destroy tumors. The current market quotes on GURU.Markets visualized below show a capitalization of 0.09. Business development relies on test results, ignoring market cycles. The constant demand for advanced therapies transforms this sector into a resilient defensive asset, independent of the global economy.

TuHURA Biosciences - HURA Market Capitalization (period 07/04/2022 - 11/16/2026)

Metric breakdowns and analytics for TuHURA Biosciences Inc. (HURA)

Fundamental company valuation:TuHURA Biosciences HURA
Product sample of TuHURA Biosciences

Market capitalization determines the total value of all a company's shares, reflecting the market valuation of the business. Comparing this volume with competitors allows an investor to determine the scale of the issuer. By analyzing the market capitalization of TuHURA Biosciences, Inc. (HURA), one can track the current value of 0.09. The trend of this indicator here directly depends on successes in the development of oncology drugs. A failure in clinical trials or a funding deficit will inevitably lead to a sharp reduction in this value.

Competitors of TuHURA Biosciences, Inc. (HURA)

Market Value BeiGene Ltd ONC|Market Capitalization Halozyme Corp HALO|RVMD - Market Value|Market Valuation AAPG|CG Oncology Corp (CGON) - Market Value|Market Capitalization URGN|BCAX (Bicara Corp) - Market Capitalization|Market Valuation Personalis Corp (PSNL)|Market Capitalization ERAS|Market Capitalization delcath.com (DCTH)|Market Value YmAbs YMAB|AURA: Market Capitalization|Candel Therapeutics, Inc. - Market Capitalization|Accuray Inc. (ARAY) - Market Valuation|SELLAS Life Sciences Group Inc. (SLS) - Market Value|Market Value actuatetherapeutics.com (ACTU)|Market Value Citius Oncology|TARA: Market Value|Market Valuation FATE (Fate Therapeutics Corp)|WHWK (Aadi Bioscience) - Market Value|Market Capitalization TCRX (TScan Therapeutics)|CSBR - Market Valuation|XBIT: Market Valuation|Market Value CVM (cel-sci.com)|OS Therapies Inc (OSTX) - Market Value|Radiopharm Theranostics - Market Value|ARTV (Artiva Biotherapeutics Inc.) - Market Capitalization|Market Capitalization Adlai Nortye Ltd.|Market Valuation VERU (Veru)|Market Value TPST|Market Value Xilio XLO|Renovaro Inc. (RENB) - Market Value|MURA - Market Value|Market Capitalization Kairos Pharma KAPA|OKUR (OnKure Therapeutics) - Market Valuation|Market Value CytoMed (GDTC)|Market Value Curis|Market Value APLM|Market Value tharimmune.com (THAR)|Market Valuation Advanced Biomed ADVB|Genprex, Inc - Market Valuation|Market Value CLDI|sunshinebiopharma.com - Market Capitalization|Market Value XBIO (xeneticbio.com)|SLRX (Salarius Pharmaceuticals) - Market Valuation|PPBT - Market Capitalization|Market Value American Oncology Network Inc|BGNE (BeiGene) - Market Value|Market Valuation CKPT (Checkpoint Therapeutics, Inc)|ELEV - Market Value|Market Capitalization ICAD (iCAD Inc.)|Ikena (IKNA) - Market Value|NTBL: Market Valuation|VIRX - Market Capitalization|MorphoSys Corp (MOR) - Market Value|Market Valuation NAYA Bio|Market Value Ascentage Pharma Group